Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vandetanib with Carboplatin and Paclitaxel in Resectable NSCLC
NCT00459121Phase 2Terminated
- Sponsor
- Barbara Ann Karmanos Cancer Institute
- Start
- Jul 2007
- Primary completion
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vandetanib in non-small cell lung cancer (NSCLC), sponsored by Barbara Ann Karmanos Cancer Institute. Started Jul 2007; status: terminated.
02
Drugs
vandetanib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00459121.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00459121.